A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
Case report of amiodarone-associated allergic pneumonitis amidst the COVID-19 pandemic
Reviews in cardiovascular medicine
Amiodarone is a common antiarrhythmic drug that is utilised in clinical practice and is associated with pulmonary toxicity. The most common form of pulmonary complication is interstitial pneumonitis which is treated with discontinuation of amiodarone and initiation of corticosteroids. Amiodarone-induced pulmonary eosinophilia is a rare complication of amiodarone therapy, with blood and pulmonary eosinophilia the predominant features. During the COVID-19 era, the incidence of delay in treatmentdoi:10.31083/j.rcm.2021.01.267 pmid:33792260 fatcat:wdxvihevr5hutj2nk2gii225si